Reveal HealthTech raises $7.2M Series A led by Leo Capital to power the next wave of AI-driven healthcare

Reveal HealthTech 获得由 Leo Capital 领投的 720 万美元 A 轮融资，推动下一波人工智能驱动的医疗保健发展。

NEW YORK and BANGALORE, India, September 3, 2025-- Reveal HealthTech, a specialized AI transformation partner for U.S. healthcare and life-sciences companies, today announced its $7.2M Series A round led by Leo Capital with participation from Sanos Capital. Founded in 2023 and incubated by W Health Ventures and 2070 Health, Reveal has quickly built a reputation as the 'healthcare AI specialist' at the intersection of cutting-edge AI and deep healthcare expertise..

纽约和印度班加罗尔，2025年9月3日——Reveal HealthTech是一家专注于为美国医疗保健和生命科学公司提供人工智能转型服务的合作伙伴，今天宣布其由Leo Capital领投、Sanos Capital参与的720万美元A轮融资。Reveal成立于2023年，由W Health Ventures和2070 Health孵化，迅速在尖端人工智能与深厚的医疗专业知识交汇领域建立了“医疗AI专家”的声誉。

Reveal helps healthcare organizations identify their most valuable problems and build safe, clinically relevant systems to solve them. 'Every year, across hundreds of thousands of patient touchpoints, we've seen the profound impact that compassion and intelligence can have when woven into care. At Essen Health Care, we have long envisioned what it would mean if every interaction reflected empathy and personalization.

Reveal帮助医疗机构识别最有价值的问题，并建立安全、临床相关的系统来解决这些问题。 “每年，在数十万个患者接触点中，我们看到了将同情心和智慧融入护理时产生的深远影响。在Essen Health Care，我们长期以来一直在设想，如果每次互动都能体现同理心和个性化，那将会意味着什么。”

With Reveal, that vision is becoming reality. By acting on data in real-time, we're not only improving patient experiences but also easing the burden on clinicians,' said Dr. Sumir Sahgal, founder and Chief Medical Officer of Essen Health Care, a New York-based fully integrated healthcare delivery network..

“通过Reveal，这一愿景正在成为现实。通过实时处理数据，我们不仅改善了患者的体验，还减轻了临床医生的负担，”总部位于纽约的全集成医疗交付网络Essen Health Care的创始人兼首席医疗官Sumir Sahgal博士说道。

AI in healthcare is no longer an experiment at the fringes, but is redefining how patients are diagnosed, how treatments are delivered, and how healthcare companies operate. In this landscape, Reveal HealthTech is positioned as a catalyst driving AI adoption through its world-class team that brings the best of academic excellence (from MIT, Harvard Medical, UC Berkeley amongst others) and decades of technology innovation experience (from Boston Children's, Mass Gen, SpaceX, NASA, Athena Health, Infosys and many others)..

医疗领域的人工智能不再是一个边缘实验，而是正在重新定义患者的诊断方式、治疗的交付方式以及医疗公司的运营方式。在这一背景下，Reveal HealthTech 通过其世界级团队推动人工智能的应用，该团队汇集了来自麻省理工学院、哈佛医学院、加州大学伯克利分校等顶尖学术机构的卓越成果，以及波士顿儿童医院、麻省总医院、SpaceX、NASA、Athena Health、Infosys 等众多机构数十年的技术创新经验，成为这一变革的催化剂。

'Our mission is simple but bold,' said Sanchit Mullick, Founder of Reveal HealthTech. 'We want to make AI the most trusted and accountable partner in healthcare, driving breakthroughs for everyone from Fortune 100 pharma companies and large healthcare delivery systems to emerging innovators in digital health.'.

“我们的使命简单而大胆，”Reveal HealthTech创始人桑奇特·穆尔利克表示，“我们希望使人工智能成为医疗保健领域最值得信赖和负责任的合作伙伴，为从财富100强制药公司和大型医疗交付系统到数字健康领域的新兴创新者等所有人带来突破。”

Reveal's solutions focus on driving customer value and improving profitability of healthcare operations. Its flagship offerings include BioCanvas® which enables multimodal AI use cases such as speeding up clinical trial recruitment using AI, and Prism AI® for rapid development of intelligent agents for workflow automation.

Reveal的解决方案专注于推动客户价值和提高医疗运营的盈利能力。其旗舰产品包括BioCanvas®，它能够实现多模态AI用例，例如利用AI加速临床试验招募，以及用于快速开发智能工作流自动化代理的Prism AI®。

In a recent deployment for a $40B US medical device leader, Reveal helped improve patient adherence through AI-driven data integration and creating a re-usable blueprint for other clients..

在最近为一家 400 亿美元的美国医疗设备领导者部署的服务中，Reveal 通过人工智能驱动的数据集成提高了患者的依从性，并为其他客户创建了可重复使用的蓝图。

Leo Capital Partner Rajul Garg noted, 'Meeting with Sanchit, Dr Salim, and the AI leadership team at Reveal made it clear their superpower lies in crafting tailored solutions that demonstrate time-bound, business goodness to clients. We're very excited to support the team in its next phase of growth.' Notably, Rajul has previously co-founded Pine Labs and GlobalLogic (acquired by Apax Partners), a leading design, data, and digital engineering company..

Leo Capital合伙人拉朱尔·加格指出：“与Sanchit、萨利姆博士以及Reveal的AI领导团队会面后，我们清楚地看到，他们的超能力在于为客户量身定制解决方案，展现时效性和商业价值。我们非常期待支持团队进入下一个增长阶段。”值得一提的是，拉朱尔曾共同创立了Pine Labs和GlobalLogic（被Apax Partners收购），后者是一家领先的设计、数据和数字工程公司。

'Healthcare cannot be solved with one-size-fits-all point solutions. Reveal understands that nuance, which is why we backed them from day one. We see an incredible opportunity for Reveal to support the rapid AI adoption within the US healthcare industry,' added Dr. Pankaj Jethwani, Managing Partner at W Health Ventures..

“医疗保健问题不能通过一刀切的点解决方案来解决。Reveal 深谙这一细微之处，因此我们从一开始就支持他们。我们认为 Reveal 有机会助力美国医疗行业快速采用人工智能，”W Health Ventures 的管理合伙人潘卡·杰瑟瓦尼 (Pankaj Jethwani) 博士补充道。

The Series A funding will help Reveal expand its capabilities and solutions, strengthen its sales network, and extend its reach to more healthcare and life sciences leaders worldwide. As part of this commitment, Reveal HealthTech is also proud to join the Cipher Collective, an ECG-powered AI partner network, bringing together best-in-class health technology solutions to transform care delivery..

A轮融资将帮助Reveal扩展其能力和解决方案，加强其销售网络，并将其影响力扩展到全球更多的医疗保健和生命科学领域领导者。作为此项承诺的一部分，Reveal HealthTech也很自豪加入Cipher Collective，这是一个由心电图驱动的人工智能合作伙伴网络，汇集了最优秀的健康技术解决方案，以变革医疗服务的提供方式。

About Reveal HealthTech

关于Reveal HealthTech

Reveal HealthTech is a specialized AI transformation partner for healthcare and life sciences organizations in the US to tackle their biggest business and clinical challenges. It creates bespoke AI solutions that deliver customer value by bringing together clinical domain expertise and engineering excellence..

Reveal HealthTech 是一家专门为美国医疗保健和生命科学组织提供人工智能转型服务的合作伙伴，致力于解决他们最严峻的业务和临床挑战。该公司通过结合临床领域专业知识和工程卓越性，打造定制的 AI 解决方案，为客户创造价值。

About Leo Capital

关于Leo Capital

Leo Capital is a venture capital fund, investing in early-stage, technology-centric start-ups in the US, India, and Europe with a strong focus on cross-border opportunities. It has a portfolio of 50+ companies across domains in early seed to pre-Series A stage.

Leo Capital 是一家风险投资基金，专注于投资美国、印度和欧洲地区以技术为核心的早期初创企业，并特别关注跨境机会。该基金拥有 50 多家公司的投资组合，涵盖从早期种子阶段到 pre-Series A 阶段的多个领域。

About Sanos Capital

关于Sanos Capital

Sanos Capital is a NY-based venture capital fund dedicated to digital health. Led by experienced operators, the fund partners with visionary founders to scale technologies that transform care delivery, elevate patient experience, and drive meaningful impact across the healthcare system.

Sanos Capital是一家总部位于纽约的风险投资基金，专注于数字健康领域。该基金由经验丰富的运营者领导，与富有远见的创始人合作，扩大能够改变医疗服务、提升患者体验并在整个医疗系统中产生重大影响的技术规模。

About W Health Ventures

关于W健康风险投资公司

W Health Ventures is an early-stage venture capital firm that builds generational healthcare companies from scratch. It has a portfolio of 12+ companies focused on AI-enabled healthcare solutions in the US-India corridor and innovative care delivery models in India.

W Health Ventures 是一家早期风险投资公司，从零开始打造世代相传的医疗保健企业。其拥有12家以上的公司组合，专注于美印走廊地区的人工智能医疗解决方案以及印度的创新医疗服务模式。